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Twenty years after the discovery of oncogenes, we have 
come to Keystone to assess progress and find new path- 
ways to discovery. To begin this homage to the power of 
molecular biology, I want to go back to the historic roots 
of this discipline. Each spring there is a gathering of sci- 
entists at Cold Spring Harbor to discuss some aspect of 
contemporary biology and they are published as the Cold 
Spring Harbor Symposia on Quantitative Biology. That 
phrase, "quantitative biology" seems quaint oday--who 
among us could imagine non-quantitative biology.~ But 
those symposia re a record of a new and revolutionary 
influence on 20th century biology, the desire for quanti- 
tative measurement in a field that had been dominated 
by observation. 
I got to thinking about the phrase "quantitative biol- 
ogy" as I thought about Howard Temin's influence on 
cancer biology. He brought quantitation to tumor virol- 
ogy and changed the nature of the field. He died on Feb- 
ruary 9, 1994 and we lost one of the generative influ- 
ences on modern cancer biology. 
Howard was 59 when he died. From my perspective, he 
died young. Certainly in spirit, he died young. For those 
of you who entered oncogene research only recently, let 
me remind you of his contributions. 
Howard went from being an undergraduate at Swarth- 
more College to a graduate fellowship at Cal Tech in 
1955. He quickly set about developing the first quanti- 
tative assay for viral transformation. This assay had deep 
historic roots. When d'H6relle first described bacterial 
viruses in 1917, he recognized that they could be quan- 
titated by a plaque assay in which a single virus could 
initiate production of a clear area in a lawn of bacterial 
growth {d'H6relle 1917). Thus was born quantitative vi- 
rology. It took almost 40 years before such a technique 
could be used in animal virology because the ability to 
grow poliovirus in cultured animal cells was only dis- 
covered by Enders, Weller, and Robbins in 1949 lEnders 
et al. 1949). 
Cal Tech was the place to be for a virologist in the 
1950's. When Howard arrived there his teachers were 
Delbriick, Dulbecco, and other key members of the 
phage group, that remarkable collection of mid-20th cen- 
tury scientists who used bacteriophages a  tools for un- 
derstanding enetic principles. Delbrfick, as early as 
1939, had understood that the simplicity of the plaque 
assay for bacteriophages, and the simplicity of the vi- 
ruses themselves, allowed more rapid progress than 
could be made on other, more complicated genetic sys- 
Howard Temm. {Photo courtesy of Cold Spring Harbor Labora- 
tory Archives.I 
tems (Delbriick 1940). Dulbecco--moving from phage to 
animal viruses--had fused the insights of Delbriick and 
the Enders group to develop aplaque assay for poliovirus 
and other animal viruses in the early 1950's IDulbecco 
1952). Thus the stage was set for Howard. Working with 
Harry Rubin in Dulbecco's laboratory, he showed, in 
1958, that cell transformation by Rous sarcoma virus 
could be quantitated by a focus-forming assay on 
chicken embryo fibroblasts ITemin and Rubin 1958}. 
This opened up viral cancer esearch to the application of 
quantitative methods and led directly to separation of 
Rous sarcoma virus from its accompanying Rous associ- 
ated viruses by Hanafusa, Vogt, and their colleagues. 
That, in turn, provided the background for Stehelin, Var- 
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mus, Bishop, and Vogt to show that the src oncogene is 
an entity independent from the rest of the Rous virus 
that has its origin in cellular genetic information (Stehe- 
lin et al. 1976}. Then was born the revolution in cancer 
biology that we celebrate here this week. 
Howard Temin, of course, played an even bigger ole in 
this story. Two decades elapsed between his arrival at 
Cal Tech and the Varmus/Bishop work. Much of that 
time, there were very few people who were aware of 
Howard's work. But he was very busy. During his time at 
Cal Tech he had an insight that seemed obvious to him 
but that few others took seriously. When he left Cal 
Tech in 1960 to go to the University of Wisconsin, he 
was determined to find a way to prove this heretical 
notion but it took ten years before a way emerged. The 
heretical notion he developed while at Cal Tech was that 
Rous sarcoma virus, although an RNA virus, must be 
carried in an integrated DNA form in the infected cell. I 
once asked Renato Dulbecco when Howard first formu- 
lated this notion and he was certain that it was in the 
late 1950's because he remembered that at Howard's the- 
sis exam, Max Delbriick was very impressed with every- 
thing except Howard's speculation on a possible DNA 
intermediate in the virus growth. 
I want to spend a moment on two issues here: Why 
was Howard so certain that there was a DNA interme- 
diate and why was this heretical? To answer the first 
question we need to go back into the history of bacterio- 
phage research. After d'H6relle discovered phage in 1917, 
there ensued much confused work on what they were 
and how they acted. Part of the confusion came from the 
unrecognized existence of two kinds of phage-host rela- 
tionships, one lytic and the other lysogenic. The lyso- 
genic state was the hard one for the early workers to 
understand. Before World War II, key observations were 
made by Bumet, working in Australia [Burnet and Lush 
1936}, and by the elder Wollmans, two French scientists 
who were arrested at the Institut Pasteur and perished in 
the concentration camps of World War II {Wollman and 
Wollman 19361. Their son carried on the work after the 
war, working with Francois Jacob (Jacob and Wollman 
1961). This pre-World War II work, on a phage of Bacillus 
megaterium, showed that bacteria can harbor a phage 
genome in a noninfectious form. 
After the war, Andr6 Lwoff picked up the work and by 
1950 he had proved that each bacterium of a lysogenic B. 
megaterium strain maintains the phage genetic material 
as a prophage and he soon showed that the phage could 
be induced into lytic growth by ultraviolet light (Lwoff et 
al. 1950). Then phage h was discovered by Esther Leder- 
berg in E. coli K12 ILederberg 19511 and the field moved 
to its study because it provided a much richer experi- 
mental system. One of the oddities here is that the phage 
group was largely an American phenomenon and yet the 
key early work on lysogeny took place in the chaos and 
poverty of post-war France. Stent has suggested that this 
was a result of Delbrfick's focus on the T-even phages, 
none of which have a lysogenic phage (Stent 1963). Del- 
briick had set off a revolution by convincing the phage 
group to concentrate on the T phages of E. coli but to 
some extent became avictim of that choice and resisted 
the notion of lysogeny until it was more than evidently 
true. 
By the mid-1950% lysogeny was well-established asa 
phenomenon and it was known that the prophage was 
integrated into host cell DNA. When Howard Temin 
was looking for a model of a stable host-virns relation- 
ship, the obvious one was the lysogenic state. The issue 
is why did Howard think about this at all. Here we must 
remember that first and foremost, Howard was an exper- 
imentalist. He was always attracted by theoretical no- 
tions, and many thought of him as a theorist, but it was 
the transformed cells in the dish that were talking to 
Howard and he was listening. What they shouted at him 
was stability. The transformed state was a permanent 
one. Every transformed cell gave rise to more trans- 
formed cells. Most persuasively, he found that strains of 
Rous Virus that gave altered morphologies to cells did so 
stably--this was a key argument for the control of the 
transformed cell by the viral genome (Temin 19601. It 
was also important that cancer was an irreversible pro- 
cess of cellular change. To Howard this meant hat there 
had to be a change in the cell's DNA. 
Howard had learned the lessons of Avery and Hershey: 
DNA carries the heredity in cells. There was only one 
problem with this notion. Rous sarcoma virus was an 
RNA-containing virus. In the late 1950% it had just been 
shown that viral RNA could be infectious (Gierer and 
Schramm 1956}, so there was no difficulty with the con- 
cept of Rous sarcoma virus RNA being the carrier of 
hereditary traits. The difficulty was that RNA was gen- 
erally considered a transient molecule in cells, easily de- 
graded and with no hiding place from which it could 
direct cell metabolism indefinitely. Furthermore, there 
existed the seductive xample of bacteriophage lysogeny. 
But how could the Rous virus RNA integrate into cellu- 
lar DNA? Therein lay the puzzle. 
Howard's solution was chemically simple but without 
precedent: if the RNA were copied into DNA, then ev- 
erything would fall into line. The RNA would become 
DNA, the DNA could integrate just like a lysogenic 
phage and the integrated genome could be transcribed 
back into RNA (Temin 1974). Conceptually, a snap--but 
totally unacceptable to almost everyone then in molec- 
ular biology because it ran counter to the guiding dogma, 
that DNA makes RNA makes protein. There was no 
place in that dogma for reversing the flow of information 
and it seemed angerous to even conceive of such a pro- 
cess because of the evolutionary implications. If RNA 
could be copied into DNA, then it was possible that ex- 
perience could feed back on the genome. One could 
imagine, for instance, that learning could involve RNA 
molecules and that they might then, as DNA, become 
part of the genome. In that way, the experience of one 
generation could be transmitted to the next. Such a 
mode of inheritance seemed more efficient han the Dar- 
winian random mutation and selection but was ruled out 
by the central dogma. 
Efficiency was not the only issue. The Lysenkoists 
who controlled Soviet science believed in the inheri- 
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tance of acquired traits because it fit the Communist 
notions of the ability of the social environment to mod- 
ify behavior. If environmental events could direct inher- 
itance, they believed that in a few generations the Soviet 
state could change the fundamental nature of man. I am 
not exaggerating the political implications of what How- 
ard was thinking: when Howard and I finally proved that 
reverse transcription occurs, we heard from Soviet and 
Chinese scientists who believed that we had provided 
evidence for the inheritance of acquired characteristics. 
Howard left Cal Tech in 1960, going to the University 
of Wisconsin where he spent the rest of his life. It was 
ten years before Mizutani, a postdoctoral fellow with 
Howard, began the biochemical experiments that ledto 
their discovery of the reverse transcriptase (Temin and 
Mizutani 1970}. During those ten years, Howard never 
lost faith in his belief that there was a DNA provirus in 
infected cells. He tested that notion i  various ways but 
could not find an experiment that would convince oth- 
ers. It was a classic case of technology lagging theory. 
One experiment, I think, was fairly convincing--the 
inhibition of virus growth by actinomycin D ITemin 
1963}. This drug was shown by my doctoral mentor, 
Richard Franklin, to inhibit DNA viruses but not RNA 
viruses (Franklin and Baltimore 1962}. There were two 
exceptions: Rous sarcoma virus and influenza virus. 
Actinomycin D binds to DNA but not RNA and there- 
fore its inhibition of Rous virus seemed like a strong 
argument for a DNA intermediate. However, drug inhi- 
bition experiments are never wholly satisfying because 
of uncertainties about specificity and secondary effects. 
The influenza virus case is a good example--it does not 
have a DNA intermediate in its growth but it needs host 
cell DNA-dependent RNA synthesis to provide the caps 
for its messenger RNA. The possibility that Rous virus 
inhibition had some similar indirect explanation robbed 
Howard's experiment of its explanatory power. 
In another attempt at proving his point, Howard un- 
dertook DNA hybridization experiments to look for the 
provirus in infected cells (Temin 1964}. That sounded 
like a critical test and would have been except hat in his 
experiments he background was so high that the signal 
was ambiguous. In retrospect, Howard had actually dis- 
covered that chicken cells have endogenous viruses re- 
lated to Rous sarcoma virus but at the time, the back- 
ground merely served to obscure the signal and the ex- 
periment was not convincing. 
In the end, the experiment that finally convinced the 
world utilized an old technology. It was based on bio- 
chemistry that Arthur Kornberg and Severo Ochoa had 
pioneered in the mid-1950's (Kornberg 1989). What was 
required was merely to imagine that the DNA-depen- 
dent RNA polymerase might be packaged in the virions. 
That thought occurred to me and to Mizutani and Temin 
at about the same time (Baltimore 1970; Temin and Mi- 
zutani 1970}. Once the idea was there, the experiments 
were straightforward. For me, it was literally a few days 
between getting the required viral stocks and showing 
that the nzyme was present here. Imagining that there 
might be a polymerase in the virion was not revolution- 
ary in 1970. A few years earlier, the first virion poly- 
merases had been discovered; they were RNA polymer- 
ases in vaccinia virus and reovirus (Borsa and Graham 
19681 Kates and McAuslan 19671 Munyon et al. 1967; 
Shatkin and Sipe 1968). Earlier in 1970, I had found an 
RNA polymerase in the virions of vesicular stomatitis 
virus {Baltimore t al. 1970b--the key result that led me 
to the reverse transcriptase--but I believe that Howard 
was not aware of that work. 
In summarizing this history, I have tried to illustrate 
one of the truisms of science, that revolutionary ideas 
often have deep historic roots and clear precedents. That 
does not trivialize them: history does not provide an an- 
alytic basis for discovery, it provides analogies that may 
or may not be applicable. It is to Howard's everlasting 
credit that he saw the appropriate analogies in the lysog- 
eny model and continued that belief for more than ten 
years while others derided his efforts to convince them. 
When Howard conceived of the proviral intermediate 
in retrovirus replication, he was working in a time when 
the fundaments ofmolecular biology were being put into 
place. It was a time of many revolutionary ideas and 
experiments: elucidation of the structure of DNA, dis- 
covery of messenger RNA, realization of the role of 
transfer RNA, discovery of gene regulation, to mention 
only a few. These were biochemical and physiological 
discoveries but they had their basis in genetics. Howard 
embodied that perspective. Only genetics had the sub- 
tlety and abstraction to occupy and satisfy his analytic 
mind but his great discovery was one of an unsuspected 
biochemical reaction. 
Of the original phage group, only Dulbecco moved on 
early to working with animal cells {Kevles 1993}. That 
move was prophetic and had the practical consequence 
that Rubin and Temin responded and took up the chal- 
lenge of adapting the Cal Tech way to the cancer prob- 
lem. The Cal Tech way was to think about genetics and 
about abstract issues of molecular biology but not be 
afraid to take the experiments into biochemical and 
physiological contexts. Temin's housemate at Cal Tech 
was Matthew Meselson. He too took an abstract idea and 
made it a biochemical reality in the famous 1958 Mesel- 
son-Stahl experiment that showed the semi-conservative 
nature of DNA replication {Meselson and Stahl 1958). 
Why did Howard focus his legendary mind on the can- 
cer problem, r I have no idea what drove him to choose 
that direction but it certainly put him well ahead of his 
time. Matt Meselson said to me that he rarely discussed 
work with Howard because Howard had chosen such an 
unusual path in science, one with little obvious inter- 
section with the concerns of his co-students. I can re- 
member my first visit to Cal Tech in about 1962. There 
I found in the sub-basement the Dulbecco lab and found 
two students with whom I felt a special kinship. I sensed 
that Dulbecco was being the pathfinder of my career in 
science and, thinking back, can see how once Howard 
decided that cancer would be his preoccupation, Dulbec- 
co's lab was perhaps the only place in the world where he 
could have realized his ambitions. But Dulbecco was not 
the kind of person to sell his science--I believe that 
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Howard must have made his own decisions about his 
directions and it is hard to know what drove h im to 
cancer. I can make one guess, a simple one but nonethe- 
less l ikely to be close to the truth. At that time, cancer 
was to animal cell biology what genetic mutations were 
to phage and bacteria. In the 1950's one couldn't make 
mutations in animal cells but the transformation to can- 
cer was the type of aberration that could i l luminate nor- 
mal cell behavior. Vires-induced cancer was the obvious 
choice for study and Rous sarcoma virus was the obvious 
virus. That particular choice was made at Cal Tech by 
Harry Rubin, I believe, who came to the field from a 
background in veterinary medicine. 
To finish, I thought I would share some musings on 
the present state of biology occasioned by Howard's un- 
t imely death. The 1950s to the 1970s were the heroic 
times in modem biology. The Big Questions were posed 
and answered. We came out of that era with an under- 
standing of the outlines of molecular processes. How 
about biology today? Does it offer us Big Questions as 
targets for investigation.~ How long will such questions 
be out there.~ 
There are Big Questions for biology but they are not in 
what we traditionally consider molecular biology. Mo- 
lecular biology certainly still holds many more sur- 
prises--probably enough to keep my lifetime in science 
one of continual excitement--but there are few areas of 
such confusion that we can sense a Big Surprise hiding in 
the bushes. The most recent area of pregnant contro- 
versy, the mystery of the prion, seems to have come to 
consensus even if the mechanistic aspects remain uncer- 
tain. The next years should see this worked out and will 
probably uncover mult iple examples of prion-like behav- 
ior, just as happened when RNA catalysis was first dem- 
onstrated. 
The Big Questions that are easily seen are in neuro- 
science. Here we have yet to deal effectively with the 
age-old puzzles of memory and learning, of conscious- 
ness and sleep and of how all that wiring gets put to- 
gether. A remarkable amount is happening in the field, 
however, and answers to these questions are starting to 
take shape. Discovery of multiple levels of memory con- 
solidation involving specific enzymesl recognition that a 
general principle of determining neural connections is 
the concept hat neurons that fire together wire together~ 
realization that a monkey's perception can be altered by 
focal stimulation of columns of cells in its brain--these 
and other advances are rapidly taking the mystery out of 
these Big Questions. Neuroscience has many years ahead 
of it before a satisfactory picture emerges but even the 
Big Questions are already losing some of their power. 
The Big Question that faced our field 25 years ago, 
what influence causes cancer cells to grow without con- 
trol, fell to the power of modem biology over the ensuing 
quarter-century and to ay we are comfortable that we 
have an outline of the answer. In cancer biology, like 
most other areas of biology, we have moved towards a 
science of particulars and practicalities, not principles. 
It's very satisfying to understand how a particular hu- 
man disease works and to devise an intervention but I 
am sure that more than one young scientist hankers for 
the days of the Big Questions, when a recent college 
graduate could entertain heretical thoughts about can- 
cer-inducing viruses. 
Let me end by introducing a field where the Big Ques- 
tions are as big as ever but where biology wil l  yet have an 
i l luminating entry. It is controversial nd many may not 
even want to think about it, but it is there and desper- 
ately needs i l lumination. I refer to interpersonal rela- 
tions. We are all ready to believe that our bodies reflect 
our genes and that we evolved to be what we are. But we 
are a social species that lives within a complex society. 
The particulars of that society are certainly learned and 
inherited as culture, not genes. The principles of the so- 
cial relations, however, are to a great extent a reflection 
of genetically programmed capabilities. The mating be- 
havior of animals is a good example. We know, particu- 
larly well from studies on birds, how much inheritance 
has to do with the sexual styles of individual species. 
Human language is another area where there is a glim- 
mer of understanding of the interaction of cultural par- 
ticulars with genetic determination. 
There are certainly Howard Temins out there thinking 
radical thoughts about the Big Questions of human be- 
havior and their answers are likely to bring shocking 
realizations about the biological underpinnings of hu- 
man life. First in neuroscience but later in sociobiology 
we will see these principles emerge and then become the 
basis for investigations of particulars and then rational 
intervention. It is a world that many fear because of the 
erosion of perceived flee will but it is the world of bio- 
logical reality and I, at least, believe that by facing it we 
can become richer, healthier, and more satisfied human 
beings. 
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